Recent Biosimilar Commercialization Developments | Goodwin
Insulin Biosimilars: Meitheal Pharmaceuticals, Inc. has announced an exclusive licensing agreement with Tonghua Dongbao Pharmaceuticals Co., Ltd. to commercialize Tonghua...
Source: jdsupra.com